FluoVac from Harvard Bioscience: a safe solution for anaesthetic gas evacuation
The management of anaesthetic gases is a major challenge in preclinical and veterinary research environments. The FluoVac system developed by Harvard Bioscience addresses this issue by combining safety, ergonomics and performance. Designed for small animals, this device ensures effective anaesthetic administration while simultaneously capturing excess gases, thereby reducing the risk of exposure for operators.
The FluoVac works on the principle of a double-envelope mask: an internal interface diffuses the anaesthetic agent, while the outer envelope, connected to a suction system, removes residual gases. This ingenious device limits leaks into the operating environment while ensuring the comfort and safety of the animal.
FluoVac connects easily to a standard power supply (110 or 240 V), making it compatible with existing installations. The system is designed for use exclusively with non-flammable gases, ensuring safe use.
At the heart of the system are Fluosorber cartridges, which are made of activated carbon with high adsorption capacity. These cartridges effectively neutralise halogenated gases and are easy to replace thanks to a weight indicator: when a cartridge has gained 200 g compared to its initial weight, it must be replaced. This makes maintenance simple and economical.
Compact and quiet, the FluoVac fits easily into a research environment without disrupting the team's work. Its robust design and minimal maintenance make it a durable and reliable piece of equipment. It is particularly recommended for procedures involving rodents, such as mice or rats, in surgery or light anaesthesia.
With this device, Harvard Bioscience is committed to providing a practical and effective solution for anaesthetic gas management, while meeting laboratory safety and compliance requirements. The FluoVac is therefore an essential choice for professionals who are committed to protecting both their research subjects and their staff.
